Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY22 results · Apr–Jun 2021
Pfizer reported revenue from operations of ₹749.17 crore (up 45.5% from Q1 FY21) and net profit of ₹199.91 crore (up 60.6% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 749.17 | 514.89 | +45.5% | 534.76 | +40.1% |
| Other income | 12.24 | 17.20 | −28.8% | 37.20 | −67.1% |
| Total income | 761.41 | 532.09 | +43.1% | 571.96 | +33.1% |
| Profit before tax | 268.73 | 173.34 | +55.0% | 132.09 | +103.4% |
| Net profit for the period | 199.91 | 124.45 | +60.6% | 100.55 | +98.8% |
| EPS, basic (₹) | 43.69 | 27.20 | +60.6% | 21.98 | +98.8% |
| Net margin (%) | 26.7 | 24.2 | 18.8 |
Standalone
- Filed with BSE
- 28 Jul 2021, 15:24 IST
- Board meeting
- 28 Jul 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE